NovoCure LimitedNVCRNASDAQ
LOADING
|||
Revenue Growth Recovery in Progress
Trending higher, below historical average, slight contraction.
Left:
||||
Year-over-year revenue growth rate
Latest
5.29%
↓ 35% below average
Average (39q)
8.15%
Historical baseline
Range
High:39.53%
Low:-7.01%
CAGR
-5.0%
Modest growth trend
| Period | Value |
|---|---|
| Q3 2025 | 5.29% |
| Q2 2025 | 2.46% |
| Q1 2025 | -3.89% |
| Q4 2024 | 3.98% |
| Q3 2024 | 3.15% |
| Q2 2024 | 8.56% |
| Q1 2024 | 3.53% |
| Q4 2023 | 5.08% |
| Q3 2023 | 1.01% |
| Q2 2023 | 3.17% |
| Q1 2023 | -4.86% |
| Q4 2022 | -1.96% |
| Q3 2022 | -7.01% |
| Q2 2022 | 2.41% |
| Q1 2022 | 3.25% |
| Q4 2021 | -0.29% |
| Q3 2021 | 0.07% |
| Q2 2021 | -0.87% |
| Q1 2021 | -6.43% |
| Q4 2020 | 8.51% |
| Q3 2020 | 14.44% |
| Q2 2020 | 13.84% |
| Q1 2020 | 2.61% |
| Q4 2019 | 7.79% |
| Q3 2019 | 6.17% |
| Q2 2019 | 18.28% |
| Q1 2019 | 5.22% |
| Q4 2018 | 7.59% |
| Q3 2018 | 5.27% |
| Q2 2018 | 18.01% |
| Q1 2018 | -2.86% |
| Q4 2017 | 7.09% |
| Q3 2017 | 30.57% |
| Q2 2017 | 10.02% |
| Q1 2017 | 15.34% |
| Q4 2016 | 39.53% |
| Q3 2016 | 20.96% |
| Q2 2016 | 37.28% |
| Q1 2016 | 5.41% |
| Q4 2015 | 38.31% |